SMITHKLINE KYTRIL, FAMVIR COULD BE DIVESTMENT CANDIDATES IN MERGER WITH GLAXO; MERGER WOULD GIVE GLAXO ENTRY INTO PBM, CLINICAL LABS BUSINESSES